Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 6.38
(-1.39%)
CNY 6.38
(-1.39%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 120.89 Million CNY | -21.42% |
| 2022 | 165.21 Million CNY | -6.42% |
| 2021 | 176.55 Million CNY | 18.22% |
| 2020 | 149.33 Million CNY | -19.08% |
| 2019 | 184.54 Million CNY | 5.96% |
| 2018 | 174.16 Million CNY | 36.59% |
| 2017 | 127.5 Million CNY | 78.42% |
| 2016 | 71.46 Million CNY | 8.39% |
| 2015 | 65.93 Million CNY | -7.62% |
| 2014 | 71.37 Million CNY | 42.89% |
| 2013 | 49.94 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 22.4 Million CNY | 42.37% |
| 2024 Q2 | 38.45 Million CNY | 71.61% |
| 2024 Q3 | 28.49 Million CNY | -16.5% |
| 2023 Q1 | 39.43 Million CNY | -23.72% |
| 2023 Q3 | 32.88 Million CNY | -21.25% |
| 2023 Q2 | 41.75 Million CNY | 5.88% |
| 2023 Q4 | 15.73 Million CNY | -52.14% |
| 2023 FY | 129.81 Million CNY | -21.42% |
| 2022 FY | 165.21 Million CNY | -6.42% |
| 2022 Q4 | 51.7 Million CNY | 57.74% |
| 2022 Q3 | 32.77 Million CNY | -26.46% |
| 2022 Q2 | 44.57 Million CNY | 23.26% |
| 2022 Q1 | 36.16 Million CNY | -40.04% |
| 2021 Q3 | 33.47 Million CNY | -17.8% |
| 2021 Q4 | 60.31 Million CNY | 80.2% |
| 2021 Q1 | 42.04 Million CNY | 21.73% |
| 2021 FY | 176.55 Million CNY | 18.22% |
| 2021 Q2 | 40.71 Million CNY | -3.16% |
| 2020 Q4 | 34.54 Million CNY | -14.09% |
| 2020 Q3 | 40.2 Million CNY | -14.64% |
| 2020 Q2 | 47.1 Million CNY | 71.41% |
| 2020 Q1 | 27.48 Million CNY | -35.21% |
| 2020 FY | 149.33 Million CNY | -19.08% |
| 2019 FY | 184.54 Million CNY | 5.96% |
| 2019 Q4 | 42.41 Million CNY | 29.81% |
| 2019 Q3 | 32.67 Million CNY | -54.21% |
| 2019 Q1 | 38.09 Million CNY | -20.81% |
| 2019 Q2 | 71.35 Million CNY | 87.3% |
| 2018 Q1 | 37.99 Million CNY | 473.91% |
| 2018 Q3 | 35.92 Million CNY | -31.09% |
| 2018 Q4 | 48.1 Million CNY | 33.9% |
| 2018 FY | 174.16 Million CNY | 36.59% |
| 2018 Q2 | 52.14 Million CNY | 37.23% |
| 2017 Q4 | 6.62 Million CNY | -89.47% |
| 2017 FY | 127.5 Million CNY | 78.42% |
| 2017 Q1 | 18.12 Million CNY | -23.36% |
| 2017 Q3 | 62.86 Million CNY | 57.56% |
| 2017 Q2 | 39.9 Million CNY | 120.19% |
| 2016 Q4 | 23.64 Million CNY | 27.0% |
| 2016 Q3 | 18.61 Million CNY | 0.0% |
| 2016 FY | 71.46 Million CNY | 8.39% |
| 2015 FY | 65.93 Million CNY | -7.62% |
| 2014 FY | 71.37 Million CNY | 42.89% |
| 2013 FY | 49.94 Million CNY | 0.0% |